Cargando…
Updated diagnostic criteria for neuromyelitis optica spectrum disorder: Similar outcomes of previously separate cohorts
BACKGROUND: The specificity of the aquaporin-4 antibody to predict recurrent inflammatory central nervous system disease has led to the design of the 2015 neuromyelitis optica spectrum disorder criteria which capture all aquaporin-4 antibody seropositive patients. OBJECTIVE: The purpose of this stud...
Autores principales: | McCreary, M, Mealy, MA, Wingerchuk, DM, Levy, M, DeSena, A, Greenberg, BM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293372/ https://www.ncbi.nlm.nih.gov/pubmed/30559975 http://dx.doi.org/10.1177/2055217318815925 |
Ejemplares similares
-
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
por: Wingerchuk, Dean M., et al.
Publicado: (2015) -
Early indicators of relapses vs pseudorelapses in neuromyelitis optica spectrum disorder
por: Kessler, Remi A., et al.
Publicado: (2016) -
Update on biomarkers in neuromyelitis optica
por: Melamed, Esther, et al.
Publicado: (2015) -
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica
por: Levy, Michael, et al.
Publicado: (2014) -
B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20
por: Levy, Michael, et al.
Publicado: (2021)